课题基金 / 基金详情

Analysis of transcriptional control mechanism for the expression of type I collagen and related gene in fibrotic skin disorders

Analysis of transcriptional control mechanism for the expression of type I collagen and related gene in fibrotic skin disorders
纤维化皮肤病中I型胶原及相关基因表达的转录控制机制分析
批准号:
14570799
负责人:
HATAMOCHI Atsushi
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

HATAMOCHI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
系统性硬化症(SSc)等纤维化性皮肤病的特点是皮肤和各种内脏器官中胶原蛋白的过度积累。胶原蛋白的积累被认为是纤维母细胞中胶原蛋白转录增强的结果。I型胶原蛋白是真皮中含量最多的蛋白,由两条α1(I)链和一条α2(I)链协调表达组成。Co1F1是一种特异性结合α2(I)胶原启动子片段的DNA结合蛋白,位于α2(I)胶原基因转录起始上游-400bp处,可激活α2(I)胶原基因的转录。我们对α2(T)胶原基因转录因子多肽的部分序列和cDNA克隆进行了研究。经序列特异性DNA亲和层析纯化的蛋白由42kDa和40.5 kDa的多肽组成。从42kDa多肽中提取的肽片段序列与Purα相同,Purα是一种与人类c-myc基因上游区域结合的核蛋白。40kDa多肽的部分片段与Purβ相同,已部分测序,与Purα具有较强的同源性。对Purβ cDNA进行全长测序。Purα和Purβ的演绎氨基酸序列同源性为61.4%。对于SSc患者,没有一种治疗方式能带来令人满意的改善。因此,我们想要展示红霉素类似物EM703对正常和硬皮病成纤维细胞胶原转录的影响。EM703以剂量依赖性的方式降低正常成纤维细胞的胶原生成(最大减少40%)和α1(I)胶原mRNA水平(最大减少30%)。EM703显著降低了所有9种SSc成纤维细胞。在荧光素酶实验中,COL1A1转录下调30%。EM703处理的成纤维细胞核提取物降低了ccaat结合因子(CBF)的结合活性,而SP1的结合活性不变。这些结果表明,EM703不仅在正常情况下,而且在SSc成纤维细胞中也能减少I型胶原的转录,并且CBF参与了这种减少的表达。少
英文摘要
Fibrotic skin diseases such as systemic sclerosis(SSc) are characterized by excessive accumulation of collagen in the skin and a variety of internal organs. The accumulation of collagen is thought to result from enhanced transcription of collagen in fibroblasts. Collagen type I, a most abundant protein in the dermis, consists of two α1(I) chain and one α2(I) chain which are coordinately expressed. Co1F1, a DNA binding protein which specifically binds to a segment of the α 2(I)collagen promoter at -400bp upstream of the start of transcription, activates transcription of the α2(I)collagen gene in vitro. We investigated on the partial sequences of polypeptide and the cDNA cloning of this transcriptional factor of the α2(T)collagen gene. The protein purified by sequence-specific DNA affinity chromatography were found to consist of 42kDa and 40.5 kDa polypeptides. Sequences of peptide fragments from 42kDa polypeptide were identical to Purα, which is a nuclear protein which has been reported … More to binds to a upstream region of human c-myc gene. Some of those from 40kDa polypeptide were identical to Purβ, has been partially sequenced and has regions of strong homology to Purα. Full length of Purβ cDNA were sequenced. The deductive amino acid sequences of Purα and Purβ showed 61.4% homology. None of treatment modalities for patients with SSc has brought satisfactory improvement. We, therefore, would like to present effects of the Erythromycin analog EM703 on collagen transcription in normal and scleroderma fibroblasts. EM703 reduced collagen production(to 40% in maximum) and mRNA levels of α1(I) collagen(to 30% in maximum) in a dose dependent manner in normal fibroblasts. EM703 markedly reduced those in all 9 SSc fibroblasts. COL1A1 transcription was down-regulated by 30% in the Luciferase assay. Nuclear extracts from fibroblasts treated with EM703 reduced the CCAAT-binding factor(CBF) binding activity, whereas SP1 binding activity was unchanged. These results suggest that EM703 reduce the type I collagen transcription not only in normal but also in SSc fibroblasts and that the CBF is involved in this reduced expression. Less
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Ehlers-Danlos syndrome type IV with few extrathoracic finding : a newly recognized point mutation in the COL3A1 gene.
Ehlers-Danlos 综合征 IV 型,很少有胸腔外发现:COL3A1 基因中新发现的点突变。
DOI: --
发表时间: 2002
期刊: Eur Respir J 19・1
影响因子: --
作者: [Kakimura T, Saeki H, et al., Watanabe A et al.]
通讯作者: Watanabe A et al.
Akira Watanabe: "Ehlers-Danlos syndrome type IV with few extrathoracic findings : a new recognized point mutation in the COL3A1 gene"Eur Respir J. 19(1). 195-198 (2002)
Akira Watanabe:“几乎没有胸腔外发现的 IV 型 Ehlers-Danlos 综合征:COL3A1 基因中新识别的点突变”Eur Respir J. 19(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间: 2003
期刊: J Rheumatol 30・6
影响因子: --
作者: [Kuwana M et al.]
通讯作者: Kuwana M et al.
DOI: 10.1183/09031936.02.00219202
发表时间: 2002-01-01
期刊: EUROPEAN RESPIRATORY JOURNAL
影响因子: 24.3
作者: [Watanabe, A, Kawabata, Y, Kuriyama, T]
通讯作者: Kuriyama, T
共 10 条
    Analysis of the genetic and phenotypic findings in Japanese patients with vascular-type Ehlers-Danlos syndrom
    • 批准号:
      21591442
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.25万
    • 财政年份:
      2009
    • 负责人:
      HATAMOCHI Atsushi
    • 依托单位:
    Analysis of transcriptional control mechanism for the expression of type I collagen gene in fibrotic skin disorders
    • 批准号:
      10670779
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.73万
    • 财政年份:
      1998
    • 负责人:
      HATAMOCHI Atsushi
    • 依托单位:
    Transcriptional control mechanism for the expression of type I collagen gene in fibrotic skin disorders and related diseases
    • 批准号:
      08670948
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      HATAMOCHI Atsushi
    • 依托单位:
    Transcriptional control mechanism for the expression of alpha1 (1) collagen gene in fibrotic skin disorders
    国内基金
    海外基金
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
    • 批准号:
      82371745
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张文倩
    • 依托单位:
    转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
    • 批准号:
      82371704
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      徐步芳
    • 依托单位:
    小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究